Anixa Biosciences Inc.

(ANIX) Trade

By |

Profile

Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumors which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company also examines emerging technologies in complementary or related fields for further development and commercialization.

Contact Information

Website: www.anixa.com
Main Phone: +1 408 708-9808
Address: 3150 Almaden Expressway
Address 2: Suite 250
State: CA
City / Town: San Jose
Country: USA
Postal Code: 95118

Issuer Information

Exchange: NSC
CEO: Amit Kumar
Employees: 8
NAICS: Testing Laboratories(541380)


Gathering Data... Please wait

Profile

Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumors which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company also examines emerging technologies in complementary or related fields for further development and commercialization.

Contact Information

Website: www.anixa.com
Main Phone: +1 408 708-9808
Address: 3150 Almaden Expressway
Address 2: Suite 250
State: CA
City / Town: San Jose
Country: USA
Postal Code: 95118

Issuer Information

Exchange: NSC
CEO: Amit Kumar
Employees: 8
NAICS: Testing Laboratories(541380)
$ 4.10 $ -0.15 (-3.53%)
Last Price 4.10 Change $ -0.15 Change % -3.53 Tick N/A
Bid 3.98 Bid Size 1,200.00 Ask 4.35 Ask Size 1,400.00
Open 4.22 High 4.28 Low 4.04 Prev Close 4.25
Last Trade Volume 49,399 52 Wk Hi 6.86 52 Wk Low 3.10
Market Cap 82.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,096,743.00 EPS (TTM) -0.97 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 6 8
Number of Buys 6 7
Number of Sells 0 1
Net Activity 21842 -758
Last 10 Buys Shares
Michael J Catelani 1,000
Lewis H. Titterton 1,000
Amit Kumar 1,000
Amit Kumar 1,000
Amit Kumar 1,000
Amit Kumar 1,000
Amit Kumar 1,000
Robert A. Berman 1,000
Robert A. Berman 1,000
Amit Kumar 1,000
Last 10 Sell Shares
Richard H. Williams 1,000
Lewis H. Titterton 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 11.25
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 8.13
Standard Deviation 0 0 0 4.42
Date of Most Recent Estimate 12/05/17 12/05/17 12/05/17 10/03/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 0 0 0